Summary
Intravenous administration of the beta-adrenergic blocking drug, alprenolol, to a group of patients with severe obstructive disease of the airways caused no deterioration of symptoms and a clinically insignificant fall in FEV1 in the majority. A minor reduction in PaO2 occurred which suggests that alprenolol may cause local hypoventilation and/or pulmonary arteriovenous shunting. The presence of obstructive disease of the airways does not seem to pose an absolute contraindication to the use of alprenolol, although caution must be exercised in its use in such patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Åblad, B., Brogård, M., Ek, L.: Pharmacological properties of H 56/28 — a beta-adrenergic receptor antagonist. Acta pharmacol. (Kbh.) 25, suppl. 2, 9–40, (1967).
—, Johnsson, G., Norrby, A., Solvell, L.: Potency and time-effect relationship in man of propranolol and H 56/28 — comparative studies after oral administration. Acta pharmacol. (Kbh.) 25, suppl. 2, 85–94 (1967).
Ahlquist, R. P.: A study of the adrenotropic receptors. Amer. J. Physiol. 153, 586–599 (1948).
Beumer, H. M.: Local effects of beta-adrenergic blocking drugs in histamine sensitive asthmatics. Pharmacol. Clin. 1, 172–173 (1969).
Forsberg, S.A., Johansson, G.: Haemodynamic effects of propranolol and H 56/28 in man — a comparative study of two beta-adrenergic receptor antagonists. Acta pharmacol. (Kbh.) 25, suppl. 2, 75–83 (1967).
Johnsson, G., Norrby, A., Sølvell, L.: Potency and time-effect relationship in man of propranolol and H 56/28, I: Comparative studies after intravenous administration. II: Studies on the ratio of equipotent oral and intravenous doses. Acta pharmacol. (Kbh.) 25, suppl. 2, 95–105 (1967).
MacDonald, A. G., McNeill, R. S.: A comparison of the effect on airway resistance of a new beta-blocking drug, ICI 50172 and propranolol. Brit. J. Anaesth. 40, 508–510 (1968).
McNeill, R. S., Ingram, C. G.: Effect of propranolol on ventilatory function. Amer. J. Cardiol. 18, 473–475 (1966).
Palmer, K. N. V., Diament, A. N.: Spirometry and bloodgas tension in bronchial asthma and chronic bronchitis. Lancet 1967 II, 383–384.
Tivenius, L., Nyberg, G.: Effect of alprenolol and propranolol on ventilatory function. Pharmacol. Clin. 2, 51–57 (1969).
Author information
Authors and Affiliations
Additional information
H 56/28, Aptin® AB Hässle, Subsidiary of AB Astra, Göteborg, Sweden.
Rights and permissions
About this article
Cite this article
Sealey, B.J. Effect of intravenous alprenolol on ventilatory function and blood gas values in established obstructive airways disease. Pharmacol. Clin. 2, 79–81 (1970). https://doi.org/10.1007/BF00420710
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00420710